In This Article:
As global markets navigate a landscape marked by record highs in major indexes and optimism surrounding AI investments, small-cap stocks have lagged behind their larger counterparts. In this environment of cautious optimism and selective growth, identifying promising opportunities requires a keen eye for companies with strong fundamentals and innovative potential.
Top 10 Undiscovered Gems With Strong Fundamentals
Name | Debt To Equity | Revenue Growth | Earnings Growth | Health Rating |
---|---|---|---|---|
Wilson Bank Holding | NA | 7.87% | 8.22% | ★★★★★★ |
Ovostar Union | 0.01% | 10.19% | 49.85% | ★★★★★★ |
Namuga | 14.66% | -1.45% | 33.57% | ★★★★★★ |
ONEJOON | 9.85% | 24.95% | 4.85% | ★★★★★☆ |
Giant Heavy Machinery Service | 17.81% | 21.88% | 48.77% | ★★★★★☆ |
Primadaya Plastisindo | 10.46% | 15.41% | 23.92% | ★★★★★☆ |
Arab Banking Corporation (B.S.C.) | 213.15% | 18.58% | 29.63% | ★★★★☆☆ |
Practic | NA | 3.63% | 6.85% | ★★★★☆☆ |
BOSQAR d.d | 94.35% | 39.11% | 23.56% | ★★★★☆☆ |
Shandong Longquan Pipe IndustryLtd | 34.82% | 2.24% | -22.15% | ★★★★☆☆ |
Underneath we present a selection of stocks filtered out by our screen.
Haw Par
Simply Wall St Value Rating: ★★★★★☆
Overview: Haw Par Corporation Limited is engaged in the manufacturing, marketing, and trading of healthcare products across Singapore, ASEAN countries, other Asian regions, and internationally, with a market capitalization of SGD2.52 billion.
Operations: Haw Par generates revenue primarily from its healthcare products, totaling SGD220.30 million. The company's market capitalization is approximately SGD2.52 billion.
Haw Par's earnings growth of 33.8% over the past year outpaces the Pharmaceuticals industry average of 8.6%, showcasing robust performance. The company holds more cash than its total debt, suggesting a strong financial position, although its debt-to-equity ratio has increased from 0.8 to 1 over five years, indicating higher leverage. With a price-to-earnings ratio of 10.8x below the Singapore market average of 12x, it appears undervalued relative to peers. High-quality earnings and positive free cash flow further highlight Haw Par’s solid footing in its sector, offering potential for continued strength and stability moving forward.
-
Click here and access our complete health analysis report to understand the dynamics of Haw Par.
-
Examine Haw Par's past performance report to understand how it has performed in the past.
Taihei Dengyo Kaisha
Simply Wall St Value Rating: ★★★★★★
Overview: Taihei Dengyo Kaisha, Ltd. operates in the plant construction industry both domestically and internationally, with a market capitalization of ¥97.77 billion.